Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results

WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial results. Full Year 2025 Financial Highlights: Total revenue for the year ended December 31, 2025 was $427,869 compared to $2,080,879 for the year ended December 31, 2024. Revenue in both periods is mainly animal health related. The Company is now focused on expanding its distribution and sales agent network